Related Experiment Videos
Genome-wide association analysis of incident coronary heart disease (CHD) in African Americans: a short report
Maja Barbalic1, Alex P Reiner, Chunyuan Wu
1Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Plos Genetics
|August 11, 2011
Summary
This study identified a novel genetic marker for coronary heart disease (CHD) risk in African Americans. This genome-wide association study (GWAS) is the first to find a CHD locus in this population.
Area of Science:
- Genetics
- Cardiovascular Disease Epidemiology
- Genomic Medicine
Background:
- African Americans experience the highest mortality rates from coronary heart disease (CHD).
- Previous genome-wide association studies (GWAS) for CHD risk have primarily focused on European-American populations, leaving a gap in understanding genetic determinants in African Americans.
- No GWAS for incident CHD had been reported for African Americans prior to this study.
Purpose of the Study:
- To conduct the first genome-wide association study (GWAS) for incident coronary heart disease (CHD) in an African American cohort.
- To identify novel genetic loci associated with CHD risk specific to the African American population.
- To validate findings in an independent cohort of African American women.
Main Methods:
- A GWAS was performed on 2,905 African Americans from the Atherosclerosis Risk in Communities (ARIC) study with 19 years of follow-up for incident CHD events.
- A significant single nucleotide polymorphism (SNP) was identified and then replicated in an independent sample of over 8,000 African American women from the Women's Health Initiative (WHI).
- The function of the associated gene (PFTK1) was investigated, noting its role in cell cycle regulation.
Main Results:
- A genome-wide significant SNP (rs1859023) at 7q21 near the PFTK1 gene was identified, showing a protective effect (HR = 0.57) against incident CHD.
- This finding was successfully replicated in the WHI cohort (HR = 0.81), confirming its association with reduced CHD risk in African American women.
- The PFTK1 gene encodes a protein kinase involved in cell cycle progression, suggesting a potential biological mechanism for its role in CHD risk.
Conclusions:
- This study reports the first genome-wide significant locus for incident coronary heart disease (CHD) identified through GWAS in an African American population.
- The identified SNP near the PFTK1 gene represents a novel genetic finding associated with CHD risk in this demographic.
- These results highlight the importance of conducting genetic association studies in diverse populations to uncover population-specific risk factors for complex diseases like CHD.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...